Olfr457 Inhibitors
Olfr457, an olfactory receptor protein, plays a crucial role in initiating neuronal responses to odorant molecules. Belonging to the G-protein-coupled receptor (GPCR) family, it shares structural characteristics with neurotransmitter and hormone receptors, mediating odorant signal transduction through G protein-mediated pathways. The olfactory receptor gene family, with Olfr457 as a prominent member, constitutes the largest in the genome. Inhibition of Olfr457 involves diverse chemical interventions. Pirenzepine acts as a muscarinic receptor antagonist, modulating downstream GPCR signaling by blocking acetylcholine binding. Suramin disrupts GPCR signaling cascades, while N-Acetylcysteine influences olfactory signaling through redox-sensitive mechanisms. U73122 inhibits phospholipase C, impacting GPCR signaling, and Wortmannin interferes with PI3-kinase, affecting GPCR-mediated processes. SB203580 targets p38 MAP kinase, altering MAPK pathways associated with olfactory signal transduction.
BAPTA-AM, a calcium chelator, modifies GPCR-mediated signaling by altering calcium-dependent processes. Bisindolylmaleimide I inhibits PKC, impacting olfactory signal transduction through downstream GPCR-related pathways. 2-Aminoethoxydiphenyl, a Rho kinase inhibitor, influences cytoskeletal dynamics associated with GPCR signaling. PD98059 disrupts the MAPK pathway, and LY294002 inhibits PI3-kinase, both affecting GPCR-related signaling cascades. Triciribine targets Akt, influencing GPCR-associated pathways. In summary, the inhibition of Olfr457 involves a spectrum of chemicals targeting various GPCR-associated pathways, modulating signal transduction and cellular processes essential for olfactory perception. These inhibitors offer a nuanced understanding of potential interventions in olfactory receptor function, opening avenues for further exploration in the intricate realm of odorant perception.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pirenzepine Dihydrochloride | 29868-97-1 | sc-204197 | 100 mg | $69.00 | 3 | |
Muscarinic receptor antagonist targeting GPCR signaling. Blocks acetylcholine binding to muscarinic receptors, indirectly influencing olfactory signal transduction by modulating downstream G protein-mediated pathways. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Polyanionic compound interfering with GPCR signaling cascades. Acts as a non-specific antagonist, potentially disrupting olfactory receptor protein function through downstream effects on G protein pathways. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Modulates cellular redox status, indirectly affecting olfactory signaling. Alters intracellular pathways related to GPCR function, potentially impacting olfactory receptor activity through redox-sensitive mechanisms. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor altering intracellular signaling pathways. Indirectly influences olfactory receptor function by disrupting PI3-kinase-dependent processes involved in GPCR-mediated signal transduction. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor impacting MAPK signaling pathways. Modulates cellular responses downstream of GPCR activation, potentially affecting olfactory receptor protein function through the MAPK cascade. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator affecting GPCR-mediated signal transduction. Alters calcium-dependent processes, indirectly influencing olfactory receptor protein function by modulating downstream signaling cascades. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor targeting downstream GPCR signaling. Modifies intracellular pathways involved in olfactory signal transduction, potentially impacting olfactory receptor protein function through PKC-mediated processes. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Rho kinase inhibitor affecting GPCR-related cytoskeletal dynamics. Indirectly influences olfactory receptor protein function by altering cellular processes associated with GPCR-mediated signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor disrupting MAPK pathway. Influences GPCR-mediated signal transduction, potentially affecting olfactory receptor protein function through the downstream modulation of MAPK signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3-kinase inhibitor impacting GPCR-related signaling pathways. Modulates intracellular processes, indirectly influencing olfactory receptor protein function through the disruption of PI3-kinase-dependent cascades. | ||||||